Analysts expect CryoLife, Inc. (NYSE:CRY) to report $0.09 EPS on February, 21.They anticipate $0.03 EPS change or 25.00% from last quarter’s $0.12 EPS. CRY’s profit would be $3.25 million giving it 48.47 P/E if the $0.09 EPS is correct. After having $0.08 EPS previously, CryoLife, Inc.’s analysts see 12.50% EPS growth. The stock increased 2.05% or $0.35 during the last trading session, reaching $17.45. About 77,025 shares traded. CryoLife, Inc. (NYSE:CRY) has risen 60.65% since February 15, 2017 and is uptrending. It has outperformed by 43.95% the S&P500.
Heartland Financial USA, Inc., a multi-bank holding company, provides commercial and consumer banking services to individuals and businesses in the United States. The company has market cap of $1.58 billion. It accepts various deposit products, including checking and other demand deposit accounts, NOW accounts, savings accounts, money market accounts, certificates of deposit, individual retirement accounts, health savings accounts, and other time deposits. It has a 19.9 P/E ratio. The firm also offers commercial and industrial loans; commercial real estate loans; small business loans; agricultural loans; real estate mortgage loans; consumer loans comprising motor vehicle loans, home improvement loans, home equity line of credit, and fixed rate home equity and personal lines of credit; and credit cards for commercial, business, and personal use.
Dubuque Bank & Trust Co holds 12.83% of its portfolio in Heartland Financial USA, Inc. for 1.58 million shares. Walthausen & Co. Llc owns 259,489 shares or 1.2% of their US portfolio. Moreover, At Bancorp has 0.75% invested in the company for 133,357 shares. The Missouri-based Financial Counselors Inc has invested 0.73% in the stock. Piermont Capital Management Inc., a Missouri-based fund reported 34,370 shares.
The stock increased 1.74% or $0.9 during the last trading session, reaching $52.65. About 68,086 shares traded. Heartland Financial USA, Inc. (HTLF) has risen 36.11% since February 15, 2017 and is uptrending. It has outperformed by 19.41% the S&P500.
Investors sentiment decreased to 1.59 in 2017 Q3. Its down 0.23, from 1.82 in 2017Q2. It dropped, as 14 investors sold CryoLife, Inc. shares while 27 reduced holdings. 18 funds opened positions while 47 raised stakes. 23.69 million shares or 6.06% more from 22.34 million shares in 2017Q2 were reported. Essex Inv Management Company Lc accumulated 91,641 shares or 0.28% of the stock. Penn Cap Mgmt owns 75,120 shares. Synovus Financial Corp invested in 0% or 10,257 shares. First Mercantile Tru invested in 5,508 shares or 0.02% of the stock. Ameriprise Finance reported 0% in CryoLife, Inc. (NYSE:CRY). Guggenheim Cap Lc has invested 0% in CryoLife, Inc. (NYSE:CRY). Vanguard owns 1.72M shares. Timpani Cap Mngmt Llc holds 0.75% of its portfolio in CryoLife, Inc. (NYSE:CRY) for 90,426 shares. California Pub Employees Retirement System reported 0% in CryoLife, Inc. (NYSE:CRY). Commercial Bank Of Montreal Can has 0% invested in CryoLife, Inc. (NYSE:CRY). Barclays Public Limited Co has 773 shares for 0% of their portfolio. Mackenzie Financial Corp holds 0% or 17,192 shares. Kbc Grp Incorporated Nv holds 13,447 shares. D E Shaw And reported 33,350 shares stake. Ny State Common Retirement Fund invested in 32,300 shares.
Since September 5, 2017, it had 0 insider purchases, and 4 sales for $2.84 million activity. $45,600 worth of CryoLife, Inc. (NYSE:CRY) was sold by Benson James on Monday, October 2. 125,000 CryoLife, Inc. (NYSE:CRY) shares with value of $2.75 million were sold by Mackin James P. $20,000 worth of stock was sold by RONALD C ELKINS on Friday, December 15.
CryoLife, Inc., together with its subsidiaries, makes and distributes medical devices worldwide. The company has market cap of $630.64 million. It also processes and distributes implantable human tissues for use in cardiac and vascular surgeries. It has a 62.54 P/E ratio. The firm operates in two divisions, Medical Devices and Preservation Services.
Among 4 analysts covering Cryolife (NYSE:CRY), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cryolife had 11 analyst reports since April 13, 2016 according to SRatingsIntel. On Sunday, October 8 the stock rating was maintained by Canaccord Genuity with “Buy”. The company was upgraded on Friday, February 17 by Ladenburg Thalmann. The stock of CryoLife, Inc. (NYSE:CRY) has “Buy” rating given on Tuesday, October 31 by Canaccord Genuity. Canaccord Genuity initiated the stock with “Buy” rating in Wednesday, April 13 report. The stock of CryoLife, Inc. (NYSE:CRY) has “Buy” rating given on Tuesday, January 2 by Canaccord Genuity. On Monday, May 1 the stock rating was maintained by Northland Capital with “Buy”. Northland Capital initiated the shares of CRY in report on Monday, January 9 with “Outperform” rating. The rating was maintained by Canaccord Genuity with “Buy” on Tuesday, July 25. The stock of CryoLife, Inc. (NYSE:CRY) earned “Buy” rating by Northland Capital on Monday, November 13. Northland Capital maintained the stock with “Buy” rating in Tuesday, July 25 report.